NEW YORK (GenomeWeb) – CareDx announced today that it has closed a previously announced $7.8 million public stock offering.

The molecular diagnostics company said it sold about 2.3 million shares of common stock at $4 per share. Piper Jaffray acted as sole manager for the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.